Orbem has announced the closing of a €55.5 million Series B funding round. The round was led by Dutch deeptech investor Innovation Industries. Participants also included French venture capital fund Supernova Invest, existing investors General Catalyst, 83North, The Venture Collective, and several angel investors. Orbem will use the capital to accelerate its international expansion and the further development of its AI-powered MRI technology.
Orbem develops a Solution, which aims to make magnetic resonance imaging (MRI) fast, affordable, and scalable for industrial applications. Pursue This enables the non-invasive analysis of biological materials on a large scale and simultaneously builds a comprehensive biological dataset. In the poultry industry, Orbem is one of the leading providers of in-ovo sexing technology in Europe. Last year, the startup also launched another product that detects the fertilization status of eggs before incubation.
Proven technology for the poultry industry
With the flagship product Genus Focus The Orbem visualizes the internal structures of an egg using AI-assisted MRI. The system determines the sex of an embryo in under a second and completely avoids invasive procedures. The Orbem thus offers an animal-friendly alternative to practices that raise ethical and legal concerns. In addition, the company introduced Genus Scale A solution has been launched that identifies unfertilized eggs at an early stage. This allows hatcheries to reduce food waste, save incubator capacity, and open up additional revenue streams.
Focus on expansion and new markets
With this Series B funding, Orbem is accelerating its expansion, particularly in the United States. The company opened an office in Houston, Texas, in 2025. Furthermore, Orbem plans to expand its platform for the poultry industry and is working on applications for plant-based agricultural products such as avocados, mangoes, and watermelons. In the long term, Orbem is also pursuing the application of its technology in the healthcare sector.
Pedro Gómez, co-founder and CEO of Orbem, explains:
“We are the first and, so far, only company in the world to enable the use of MRI in less than a second and without human intervention. It all started with the poultry industry, where we were the first to provide information hidden deep beneath the eggshell. But that was just the beginning. This new funding round allows us to accelerate our US expansion and help more food producers, and soon healthcare providers, make better, data-driven decisions. Our scalable platform and rapidly growing biological dataset provide the perfect foundation for this. We are proud of the trust our investors have placed in us and our vision of making the unseen visible.”
Pleuni Hooijman, Investment Manager at Innovation Industries, comments:
“Orbem is truly exceptional. Few companies manage to make such a complex technology accessible and scalable across so many industries. With its platform, Orbem is already reshaping entire sectors. We are delighted to be supporting Orbem on this journey.”
And Michael Thomas, Investment Director at Supernova Invest, says:
“We are incredibly excited to join forces with Orbem – a visionary company that perfectly embodies European deep-tech excellence. By combining cutting-edge AI and MRI technologies, Orbem delivers concrete solutions to some of the biggest challenges of our time: The company combats animal suffering and food waste and is building a more sustainable global food system. Our investment underscores our belief that Europe can be a leader in physical AI by transforming scientific breakthroughs into significant industrial innovations.”
